Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for CYPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 139.32M
March 31, 2026 84.38M
December 31, 2025 153.66M
September 30, 2025 2.695M
June 30, 2025 5.717M
March 31, 2025 20.84M
December 31, 2024 35.05M
September 30, 2024 48.95M
June 30, 2024 65.79M
March 31, 2024 47.37M
December 31, 2023 60.14M
September 30, 2023 72.01M
June 30, 2023 84.06M
March 31, 2023 96.04M
December 31, 2022 58.87M
September 30, 2022 70.07M
June 30, 2022 83.32M
March 31, 2022 98.56M
December 31, 2021 107.89M
Date Value
September 30, 2021 116.82M
June 30, 2021 29.88M
March 31, 2021 38.38M
December 31, 2020 46.65M
September 30, 2020 53.14M
June 30, 2020 59.73M
March 31, 2020 17.96M
December 31, 2019 -1.749M
September 30, 2019 5.562M
June 30, 2019 10.94M
March 31, 2019 17.06M
December 31, 2018 9.175M
September 30, 2018 6.628M
June 30, 2018 12.14M
March 31, 2018 16.13M
December 31, 2017 11.12M
September 30, 2017 11.58M
June 30, 2017 18.35M
March 31, 2017 24.17M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Indaptus Therapeutics, Inc. 11.37M
ACADIA Pharmaceuticals, Inc. 1.307B
Alnylam Pharmaceuticals, Inc. 1.354B
Anika Therapeutics, Inc. 137.28M
Savara, Inc. 143.66M

Shareholders Equity (Quarterly) Related Metrics